Novel Treatment to Enhance Smoking Cessation Before Cancer Surgery
2 other identifiers
interventional
40
1 country
2
Brief Summary
The purpose of this clinical trial is to determine the feasibility and efficacy of an intervention designed to increase rates of tobacco abstinence for cancer patients before their cancer surgery.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Oct 2014
Typical duration for not_applicable
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
October 1, 2014
CompletedFirst Submitted
Initial submission to the registry
November 17, 2014
CompletedFirst Posted
Study publicly available on registry
March 30, 2015
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 1, 2017
CompletedStudy Completion
Last participant's last visit for all outcomes
September 1, 2017
CompletedMarch 9, 2020
March 1, 2020
2.9 years
November 17, 2014
March 4, 2020
Conditions
Outcome Measures
Primary Outcomes (1)
Pre Surgery Smoking Abstinence
Participants will be classified as succeeded or failed in cessation based on a definition of 1 week of abstinence from cigarettes leading up to the day of their surgery based on self-report and confirmed with biochemical verification (CO≤6ppm). For participants who are classified as abstinent, a chi-square will be computed comparing whether treatment with CM is superior to SC in producing a higher probability of abstinence. These data will be used to compute an effect size, Cohen's w, for smoking cessation.
Day of Surgery
Secondary Outcomes (1)
Post Surgery Smoking Abstinence
3 months
Other Outcomes (2)
Continuous Smoking Abstinence
3 months
Perioperative Complications
3 months
Study Arms (2)
Standard Care (SC)
ACTIVE COMPARATORPatients in the SC arm will receive 4 counseling sessions and nicotine patches as part of typical cessation measures delivered to patients.
Contingency Management (CM)
EXPERIMENTALPatients in the CM arm will receive monetary payment contingent on smoking abstinence (in addition to SC: 4 counseling sessions and nicotine patches).
Interventions
CM is standard care plus monetary payment delivered contingent on abstinence.
Standard of care consists of smoking cessation counseling sessions and nicotine patches.
Eligibility Criteria
You may qualify if:
- age 18 or older
- smoking ≥ 1 cigarettes per day
- CO \> 6 ppm
- diagnosed with or suspicion of any type of operable thoracic, head and neck, breast, or gynecologic cancer
- agreement on a 2-5-week pre-surgical tobacco intervention by both patient and surgeon, and 6) residence within reasonable driving distance to New Haven.
You may not qualify if:
- unstable psychiatric conditions such as suicidal ideation, acute psychosis, severe alcohol dependence, or dementia
- unstable medical conditions that have not been well controlled (e.g., acute infection requiring hospitalization) for the past 30 days
- pregnant or breastfeeding women
- those with limited decision making capacity.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Yale Universitylead
- National Cancer Institute (NCI)collaborator
Study Sites (2)
Yale Cancer Center
New Haven, Connecticut, 06510, United States
Medical University of South Carolina
Charleston, South Carolina, 29425-8350, United States
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Benjamin Toll, PhD
Yale University
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- INVESTIGATOR, OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
November 17, 2014
First Posted
March 30, 2015
Study Start
October 1, 2014
Primary Completion
September 1, 2017
Study Completion
September 1, 2017
Last Updated
March 9, 2020
Record last verified: 2020-03